[HTML] frontiersin.org

[HTML][HTML] An FGFR/AKT/SOX2 signaling axis controls pancreatic cancer stemness

MY Quan, Q Guo, J Liu, R Yang, J Bai… - Frontiers in cell and …, 2020 - frontiersin.org
Cancer stemness is associated with high malignancy and low differentiation, as well as
therapeutic resistance of tumors including pancreatic ductal adenocarcinoma (PDAC) …
被引用次数：40 相关文章
[HTML] nih.gov

[HTML][HTML] An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

MY Quan, Q Guo, J Liu, R Yang, J Bai… - Frontiers in Cell and …, 2020 - ncbi.nlm.nih.gov
Cancer stemness is associated with high malignancy and low differentiation, as well as
therapeutic resistance of tumors including pancreatic ductal adenocarcinoma (PDAC) …

An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

MY Quan, Q Guo, J Liu, R Yang… - Frontiers in Cell …, 2020 - mayoclinic.elsevierpure.com
Cancer stemness is associated with high malignancy and low differentiation, as well as
therapeutic resistance of tumors including pancreatic ductal adenocarcinoma (PDAC) …

An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness

MY Quan, Q Guo, J Liu, R Yang… - Frontiers in cell …, 2020 - pubmed.ncbi.nlm.nih.gov
Cancer stemness is associated with high malignancy and low differentiation, as well as
therapeutic resistance of tumors including pancreatic ductal adenocarcinoma (PDAC) …

An FGFR/AKT/SOX2 Signaling Axis Controls Pancreatic Cancer Stemness.

MY Quan, Q Guo, J Liu, R Yang, J Bai… - Frontiers in Cell and …, 2020 - europepmc.org
Cancer stemness is associated with high malignancy and low differentiation, as well as
therapeutic resistance of tumors including pancreatic ductal adenocarcinoma (PDAC) …